KARA DELACY: Open Payments
NPI 1942485180 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 18 payments from 11 companies in 2025. Trend: 2023 $280 · 2024 $245 · 2025 $384
Food & beverage: $339Education: $45
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $81 |
| Lilly USA, LLC | 2 | $62 |
| Novo Nordisk Inc | 2 | $39 |
| ABBVIE INC. | 2 | $36 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $35 |
| Exact Sciences Corporation | 2 | $33 |
| Dexcom, Inc. | 1 | $28 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Viatris Specialty LLC | 1 | $16 |
Products named: Veozah, UBRELVY, Cologuard Collection Kit, Dexcom G6 Transmitter, THINPREP 2000 PROCESSOR, Wegovy, SPRAVATO, MOUNJARO.
Industry payments across ID — which companies pay providers there.
